Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Atai Beckley N.V (ATAI) Research & Development: 2020-2025

Historic Research & Development for Atai Beckley N.V (ATAI) over the last 6 years, with Sep 2025 value amounting to $14.7 million.

  • Atai Beckley N.V's Research & Development rose 18.61% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year increase of 10.61%. This contributed to the annual value of $55.5 million for FY2024, which is 10.85% down from last year.
  • Per Atai Beckley N.V's latest filing, its Research & Development stood at $14.7 million for Q3 2025, which was up 32.35% from $11.1 million recorded in Q2 2025.
  • Atai Beckley N.V's 5-year Research & Development high stood at $21.9 million for Q4 2022, and its period low was $5.6 million during Q1 2021.
  • Moreover, its 3-year median value for Research & Development was $13.3 million (2023), whereas its average is $14.1 million.
  • As far as peak fluctuations go, Atai Beckley N.V's Research & Development skyrocketed by 647.48% in 2021, and later slumped by 40.20% in 2024.
  • Quarterly analysis of 5 years shows Atai Beckley N.V's Research & Development stood at $13.0 million in 2021, then soared by 68.51% to $21.9 million in 2022, then plummeted by 35.29% to $14.2 million in 2023, then surged by 33.81% to $18.9 million in 2024, then rose by 18.61% to $14.7 million in 2025.
  • Its Research & Development stands at $14.7 million for Q3 2025, versus $11.1 million for Q2 2025 and $11.3 million for Q1 2025.